Uloric Lawsuit

Uloric Overview

Patients who have suffered from cardiovascular issues after taking Uloric may be eligible to pursue a claim and seek financial compensation.

Uloric is a medication used for chronic gout management by decreasing the levels of uric acid in the blood. It is manufactured by Takeda Pharmaceuticals. Due to numerous reports of cardiovascular events, stroke, and increased risk of death among users, in February 2019 the FDA added a black box warning for cardiovascular death associated with the Uloric. As a result, lawsuits have been filed against Takeda Pharmaceuticals, claiming the company knew of Uloric’s cardiovascular side effects but failed to inform its consumers.

If you or a loved one was treated with Uloric and suffered cardiovascular problems, contact Maxwell Law Group LLP today. We can answer your questions and review your case for free.

For help understanding your options if you’ve been injured by Uloric, reach out to our firm or call (844) 525-7155.

What is Uloric?

Uloric (generic name: febuxostat) is a medication prescribed for gout, a form of inflammatory arthritis that develops in people with high levels of uric acid in the blood. It was approved by the FDA in February 2009, under manufacturer Takeda Pharmaceutical.

From 2012 to 2017, the company reportedly made $1.9 billion in sales from Uloric alone.

Uloric Quick Facts



Medication for chronic gout



Cardiovascular events and death




Takeda Pharmaceuticals

How Does Uloric Work?

The body naturally produces urate. Urate is then dissolved in the blood and excreted in the urine. In gout patients, high urate levels prevent the blood from dissolving the all the urate. The urate then builds up as needle-shaped crystals which accumulate in the joints, causing pain and inflammation.

Uloric is categorized as a xanthine oxidase inhibitor, and works by blocking urate formation, which lowers blood urate levels to a low-enough level that the normal functions of the body can dissolve the urate, thus preventing gout attacks.

uloric lawsuit overview

Risks and Warnings

In November 2017, the FDA issued a safety communication informing the public that preliminary results from a clinical trial showed an increased risk of heart-related death from Uloric compared to allopurinol, another type of gout medication.

In February 2019, the FDA decided to add a black box warning for increased risk of death from Uloric use. In addition to the warning, the FDA also limited the approved use of Uloric to patients who were not treated effectively or who experienced severe side effects from allopurinol.

The time you have to pursue a claim is limited. Do not wait to reach out to our firm or call (844) 525-7155 to see if you have a case.

Injuries from Uloric

When the FDA approved Uloric in 2009, the FDA required Takeda Pharmaceuticals to conduct a large-scale, post-marketing safety clinical trial. The study was done in more than 6,000 patients taking either allopurinol or Uloric. The study showed that Uloric users experienced an increased risk of heart-related deaths and deaths from all causes. There were 15 deaths connected to heart issues reported out of 1,000 patients taking Uloric for a year, while 26 deaths from any cause were noted. By comparison, allopurinol users experienced 11 deaths connected to heart issues and 22 deaths from any cause.

Takeda Whistleblower Lawsuit

In 2010, a former safety consultant for Takeda filed a lawsuit claiming that the company knew about Uloric’s side effects, including kidney failure, congestive heart failure, and liver failure but failed to warn consumers by not revising the drug label. However, the claim was ultimately dismissed by the U.S. District Court for the District of Massachusetts.

uloric litigation timeline

How Maxwell Law Group Can Help

If you or a loved one was treated with Uloric and suffered cardiovascular problems, contact Maxwell Law Group LLP today. We can answer your questions and review your case for free.

Call (844) 525-7155 or fill out the form below take the first step in protecting your rights.

You Deserve to be Compensated

3 + 1 =

We're On Your Side

Our attorneys are always ready to speak with you about your personal situation. Every day we help people in situations similar to yours. Our team can guide you each step of the way and make sure you get the financial compensation you deserve.

While our physical offices are in Utah and Washington DC, we offer our services nationwide. We'd be honored to discuss your case with you free of charge.

Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, don't wait to take action. Contact us today.

To speak with us directly, call (844) 525-7155. We want to hear about your situation and help you through this difficult time.

Maxwell Law Group LLP

Maxwell Law Group LLP
© 2021 All Rights Reserved

Washington DC Office

By appointment only
1101 Connecticut Avenue NW
Suite 450
Washington, D.C. 20036

Utah Office

520 N Marketplace Drive
Suite 200A
Centerville, UT 84014

ATTORNEY ADVERTISING. Nothing on this site should be taken as legal advice for any individual case or situation. This website is not intended to create, and receipt of viewing does not constitute, an attorney-client relationship. Sensitive information should not be submitted through this website as it may be considered confidential or privileged. References to prior results do not guarantee a similar outcome. The firm has attorneys licensed to practice law in Utah and Washington D.C., but the attorneys may also be admitted on an individual basis in additional state and federal courts across the United States. The location of the firm's offices are listed on this website. The firm associates with co-counsel law firms to jointly represent clients in some matters. Gregory Maxwell is the attorney responsible for the contents of this website.

Share via
Send this to a friend